• Follow us
  • EN
    Flag Indonesia ID
    Flag English EN
Logo header Biofarma Group & Bio Farma Member of Biofarma Group -01 (1)
  • About Us
    • Company Profile
      • PT Bio Farma (Persero)
      • Kimia Farma Tbk (KAEF)
      • Indofarma Tbk (INAF)
      • PT INUKI (Persero)
    • History
    • Management
      • Management Team
      • Commisioners
      • Directors
    • Our Achievement
      • Awards
      • Certification
    • Report
      • Annual Report
      • Sustainability
  • Product & Services
    • Our Distribution
    • Product & Services
      • Life Sciences
      • Providers of Health Services & Products
      • Trade, Distribution of Medicines & Medical Devices
  • Media & Information
    • News
      • All News
      • Global Roles
      • Products & Services
      • CSR
    • Health Articles
    • Health FAQ
    • Our Procurement
  • Corporation
    • Good Corporate Governance
    • Our Commitment
    • TJSL
    • LHKPN
      • Lapor
  • Career
    • Recruitment
    • FAQ
  • PPID
  • Contact Us
search

Good Corporate Governance

In order to build good corporate governance, the Company shall have a commitment, consistent, and persistent from all relevant parties, i.e : all management levels, Employees, Board of Commissioners, Government and other Stakeholders.

  • Good Corporate Governance
  • Quality Assurance Control
  • Responsibilty to Customer
  • Corporate Governance Implementation Process
  • Gratification Control Process
  • Process of Whistle Blowing System
  • Guidelines for The Board of Commisioner and Director
  • Biofarma Code of Conduct
  • Guidelines for Handling Conflict of Interest
  • Charter
    • Internal Audit Charter
    • AUDIT COMMITTEE CHARTER
    • Risk Committee Charter
  • Risk Management
  • Directors Guidelines
  • Audit Committee
  • Development Risk and GCG Committee
  • Superior Performance Assessment Criteria
Select Menu

The consistent and continuous implementation of GCG best practices is Bio Farma's full commitment in running the Company. Bio Farma's commitment in cultivating GCG best practices is actualized by continuing to accommodate dynamic changes and being open to new concepts. Therefore, the existence of the Good Corporate Governance Policy as a policy is considered necessary to be updated periodically and adjusted to the development and internal and external issues of the Company. The Corporate Governance Policy is set forth in the Joint Decree of the Board of Commissioners and Directors Number: KEP-04/DK/BF/II/2013 Number: 01023/DIR/II/2013 Dated February 22, 2013 concerning Guidelines for the Implementation of Good Corporate governance at PT Bio Farma (Persero).

The process of implementing Good Corporate governance at Bio Farma is as below:

Image

Activities that Reflect the Implementation of GCG

    1. The Compliance & Risk Management Division carries out the function of controlling and ensuring that the Company's policies, decisions, and all activities are in accordance with the provisions of laws and regulations as well as monitoring and maintaining the Company's compliance with all agreements and commitments made by the Company with third parties and following the development of laws and regulations that apply and will apply to the Company.
    2. The Company conducts value-added relationships for the Company and stakeholders.
    3. The Company sets KPIs to increase shareholder value consistently and sustainably.
    4. The CSR and General Division carries out functions to implement the Company's social and environmental responsibilities.
    5. The Company is managed with attention to occupational safety and health and environmental preservation.
    6. Directors and officers in the Company are prohibited from taking actions that have a conflict of interest and taking personal advantage, either directly or indirectly from decision-making and activities of the Company.
    7. The Board of Directors reports relevant information to Shareholders and the Board of Commissioners in the Management Report (quarterly and annual) and the Annual Report to the Board of Commissioners and Shareholders in a timely manner.
    8. The Internal Audit Unit (SPI) plans the annual work program of internal supervision and conducts supervision in accordance with what has been determined, reports the implementation of its duties to the President Director with a copy to the Board of Commissioners cq Audit Committee, contributes to the improvement/enhancement of governance, risk management and internal control processes, provides input on efforts to achieve the Company's business strategy, and monitors the follow-up of recommendations from internal and external supervision.
    9. The Corporate Secretary ensures that the Company complies with regulations on disclosure requirements in line with the implementation of GCG principles, provides information required by the Board of Directors and the Board of Commissioners periodically or at any time upon request, acts as a liaison officer, maintains and stores Company documents including but not limited to the Register of Shareholders, Special Register and minutes of meetings of the Board of Directors, meetings of the Board of Commissioners and GMS, and organizes an introduction program for newly appointed members of the Board of Directors and Board of Commissioners.
    10. The Company establishes the Company's information control procedure

  • Good Corporate Governance
  • Quality Assurance Control
  • Responsibilty to Customer
  • Corporate Governance Implementation Process
  • Gratification Control Process
  • Process of Whistle Blowing System
  • Guidelines for The Board of Commisioner and Director
  • Biofarma Code of Conduct
  • Guidelines for Handling Conflict of Interest
  • Charter
    • Internal Audit Charter
    • AUDIT COMMITTEE CHARTER
    • Risk Committee Charter
  • Risk Management
  • Directors Guidelines
  • Audit Committee
  • Development Risk and GCG Committee
  • Superior Performance Assessment Criteria

Logo biofarma

Call Center 1500810
Head Office
Jl. Pasteur No. 28, Bandung 40161,
Jawa Barat Indonesia
+62 22-2033755
+62 22 - 2041306
mail@biofarma.co.id

Breeding Facility Bio Farma
Jl. Kolonel Masturi Kav 10. Desa Kertawangi kec. Cisarua
Jawa Barat
Bio Farma Representative Office
Gd. Pakarti centre Lantai 7
Jln. Tanah Abang 3 no.23-27
Jakarta Pusat

Digital Healthcare Office Jakarta Lt. 26
Equity Tower Sudirman Central Business District (SCBD) Lot 9
Jl. Jend. Sudirman Kav. 52-53
Jakarta Selatan 12190, Indonesia
Information
  • Good Corporate Governance
  • Our Procurement
  • FAQ
  • Vaccine Production
  • Your Career
 
  • Contact Us
  • E-PPID
  • Announcement
  • I Want to
  • Media Release
Our Partner

Quick Links
  • Portal BUMN-Bio
  • Kemenkes RI
Copyright © 2023. All Rights Reserved by Bio Farma

Change Language

EN
  • About Us
    • Company Profile
      • Company Profile
      • PT Bio Farma (Persero)
      • Kimia Farma Tbk (KAEF)
      • Indofarma Tbk (INAF)
      • PT INUKI (Persero)
    • History
    • Management
      • Management Team
      • Commisioners
      • Directors
    • Our Achievement
      • Awards
      • Certification
    • Report
      • Annual Report
      • Sustainability
  • Product & Services
    • Our Distribution
    • Product & Services
      • Life Sciences
      • Providers of Health Services & Products
      • Trade, Distribution of Medicines & Medical Devices
  • Media & Information
    • News
      • All News
      • Global Roles
      • Products & Services
      • CSR
    • Health Articles
    • Health FAQ
    • Our Procurement
  • Corporation
    • Good Corporate Governance
    • Our Commitment
    • TJSL
    • LHKPN
      • Lapor
  • Career
    • Career
    • Recruitment
    • FAQ
  • PPID
  • Contact Us
  • Follow us
Change Language
  • Flag Indonesia ID
  • Flag English EN